Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen further Ameliorates Spinal Muscular Atrophy in Mice

20 Jun 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Congenital Anomalies and Fetal Surgery
Share to Neurogenetic and Muscular Disorders Research
Share to RNA modifications and cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 31230718
DOI: 10.1016/j.ajhg.2019.05.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen further Ameliorates Spinal Muscular Atrophy in MicePMID 31230718Read ↗

Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophySemantic proximity Read ↗

The Antisense Oligonucleotide Nusinersen for Treatment of Spinal Muscular AtrophySemantic proximity Read ↗

Nusinersen in the Treatment of Spinal Muscular Atrophy.Semantic proximity Read ↗

RNA-targeted drugs for neuromuscular diseasesSemantic proximity Read ↗

Therapeutic Potential of Tricyclo-DNA antisense oligonucleotidesSemantic proximity Read ↗

Antisense Oligonucleotide-Based Therapy for Neuromuscular DiseaseSemantic proximity Read ↗

Nusinersen as a Therapeutic Agent for Spinal Muscular AtrophySemantic proximity Read ↗

Antisense oligonucleotides (ASOs) in motor neuron diseases: a road to cure in light and shadeSemantic proximity Read ↗

Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and ShadeSemantic proximity Read ↗

Antisense Oligonucleotide Therapeutics for Cystic Fibrosis: Recent Developments and Perspectives.Semantic proximity Read ↗

Oligonucleotide Therapeutics for Age-Related Musculoskeletal Disorders: Successes and ChallengesSemantic proximity Read ↗

The potential of antisense oligonucleotide therapies for inherited childhood lung diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.